Krishnaswamy Yeleswaram

Insider Reports History

Entity
Individual
Location
C/O Rapport Therapeutics, 1325 Boylston St., Suite 401, Boston, MA
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Krishnaswamy Yeleswaram:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Rapport Therapeutics, Inc. Chief Development Officer Common Stock 291K $2.9M $9.98 Jun 6, 2024 Direct
Rapport Therapeutics, Inc. Chief Development Officer Stock Option (Right to Buy) 110K Feb 3, 2025 Direct

Insider Reports Filed by Krishnaswamy Yeleswaram

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RAPP Rapport Therapeutics, Inc. Feb 3, 2025 1 $0 4 Feb 4, 2025 Chief Development Officer
RAPP Rapport Therapeutics, Inc. Jun 6, 2024 1 $0 4 Jun 10, 2024 Chief Development Officer
RAPP Rapport Therapeutics, Inc. Jun 6, 2024 0 $0 3 Jun 6, 2024 Chief Development Officer